Efficacy of Lenses in Abolishing Photoparoxysmal Responses (PPRs)
Reflex Epilepsy, Photosensitive, Eyeglasses
About this trial
This is an interventional treatment trial for Reflex Epilepsy, Photosensitive focused on measuring photosensitivity, pattern sensitivity, Electroencephalography, Photic Stimulation, Pattern Stimulation, photoparoxysmal response, Light, Visible, Red Colour, Blue Light, children, epilepsy, standardized photoparoxysmal response range
Eligibility Criteria
Inclusion Criteria:
- Children and adolescents between 5-18 years with suspected or confirmed diagnosis of photosensitive epilepsy (PSE), whether they are taking antiepileptic medication or not.
Capacity to:
- maintain concentration during the procedure
- follow simple commands
- assent (under 16 years) or consent (16-18 years) to participate after understanding the purpose of the study.
Exclusion Criteria:
Presence of a condition that may compromise the ability to tolerate the procedure and/or the capacity to assent or consent, such as:
- intellectual disability
- attention-deficit/hyperactivity disorder
- autism spectrum disorders
- difficulties to understand verbal/written explanations in English
- Refusal to participate
- Generalized seizure during the EEG procedure.
- Female patients suspected or known to be pregnant.
Sites / Locations
- Birmingham Women's and Children's NHS Foundation TrustRecruiting
- Aston UniversityRecruiting
Arms of the Study
Arm 1
Experimental
5 Lenses
The five lenses will be tested in each patient following always the same specific order, with the most protective lenses tested first (Z1). Z1F133 (Zeiss Clarlet Z1) is a CE marked device manufactured by Carl Zeiss Vision International GmBH (Aalen, Germany). Our lenses are CE marked devices manufactured by Cerium Optical Products (Kent, UK).